The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease.

被引：0
|
作者：
Pallotta, RS
Barbosa, JAL
Macedo, MCMA
Saboya, R
Silva, RL
Jamra, M
Chamone, DAF
Dulley, FL
机构：
[1] Hemoctr Sao Paulo, Fundacao Prosangue, BMT Program, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4489
引用
收藏
页码：346B / 346B
页数：1
相关论文
共 50 条
  • [1] Efficacy of Mycophenolate Mofetil (MMF) in the treatment of chronic graft versus host disease.
    Lopez, F
    Parker, P
    Rodriguez, R
    Snyder, D
    Bhatia, R
    Cohen, S
    Fung, H
    Kashyap, A
    Krishnan, A
    Molina, A
    Nademanee, A
    O'Donnell, M
    Popplewell, L
    Rosenthal, J
    Sahebi, F
    Somlo, G
    Spielberger, R
    Stein, A
    Sweetman, R
    Forman, S
    BLOOD, 2001, 98 (11) : 398A - 398A
  • [2] Salvage therapy with mycophenolate mofetil and FK-506 for refractory chronic graft-versus-host disease.
    Mookerjee, B
    Altomonte, V
    Vogelsang, G
    BLOOD, 1998, 92 (10) : 457A - 457A
  • [3] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Marta Krejci
    Michael Doubek
    Tomas Buchler
    Yvona Brychtova
    Jiri Vorlicek
    Jiri Mayer
    Annals of Hematology, 2005, 84 : 681 - 685
  • [4] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Krejci, M
    Doubek, M
    Buehler, T
    Brychtova, Y
    Vorlicek, J
    Mayer, J
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 681 - 685
  • [5] Response to mycophenolate mofetil therapy for refractory chronic graft-versus-host disease
    Busca, A
    Locatelli, F
    Marmont, F
    Audisio, E
    Falda, M
    HAEMATOLOGICA, 2003, 88 (07) : 837 - 838
  • [6] Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
    Lopez, F
    Parker, P
    Nademanee, A
    Rodriguez, RT
    Al-Kadbimi, Z
    Bhatia, R
    Cohen, S
    Falk, P
    Fung, H
    Kirschbaum, M
    Krishnan, A
    Kogut, N
    Molina, A
    Nakamura, R
    O'Donnell, M
    Popplewell, L
    Pullarkat, V
    Rosenthal, P
    Sahebi, F
    Smith, E
    Snyder, D
    Somlo, G
    Spielberger, R
    Stein, A
    Sweetman, R
    Zain, J
    Forman, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 307 - 313
  • [7] Treatment of acute and chronic graft versus host disease with mycophenolate mofetil.
    Ilhan, O
    Çelebi, H
    Arat, M
    Arslan, Ö
    Akçaglayan, E
    Üstün, C
    Özcan, M
    Gürman, G
    Akan, H
    Konuk, N
    Beksaç, M
    Uysal, A
    Koç, H
    BLOOD, 1999, 94 (10) : 368B - 368B
  • [8] Treatment of refractory chronic Graft-Versus-Host disease (GVHD) with Mycophenolate Mofetil (MMF).: Preliminary results
    Moscardó, F
    Sanz, G
    Jiménez, C
    Mollá, S
    Martinez, J
    Saavedra, S
    García, I
    Andreu, R
    Regadera, A
    Plumé, G
    Martin, G
    de la Rubia, J
    Cervera, J
    Jarque, I
    Sanz, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S190 - S190
  • [9] Mycophenolate Mofetil Is Effective and Well Tolerated in the Treatment of Refractory Acute and Chronic Graft-versus-Host Disease
    Akiyoshi Takami
    Kanako Mochizuki
    Hirokazu Okumura
    Hirohito Yamazaki
    Masahide Yamazaki
    Yukio Kondo
    Hidesaku Asakura
    Shinji Nakao
    Satsuki Ito
    Yukio Suga
    International Journal of Hematology, 2006, 83 : 80 - 85
  • [10] Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease
    Takami, A
    Mochizuki, K
    Okumura, H
    Ito, S
    Suga, Y
    Yamazaki, H
    Yamazaki, M
    Kondo, Y
    Asakura, H
    Nakao, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (01) : 80 - 85
12345